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Abstract We report the cloning and kinetic characterization of
Trypanosoma cruzi deoxyuridine 5P-triphosphate nucleotidohy-
drolase (dUTPase) whose coding sequence was isolated by ge-
netic complementation in Escherichia coli. The deduced amino
acid sequence was similar to Leishmania major dUTPase
although it exhibits an amino acid insertion which is sensitive
to protease inactivation. The catalytically active species of the
enzyme is a dimer and a detailed kinetic characterization
showed that it is highly speci¢c for dUTP and dUDP. The
general observation that dUTPases from the Trypanosomatidae
di¡er in sequence, conformation and substrate speci¢city sug-
gests that a di¡erent family of dUTPases exists in certain or-
ganisms, which may be exploited as drug targets against infec-
tious diseases. ( 2002 Published by Elsevier Science B.V. on
behalf of the Federation of European Biochemical Societies.
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1. Introduction
In most organisms, uracil must be methylated to thymine
prior to its incorporation into DNA. Several enzymes play
di¡erent roles in the synthesis and maintenance of thymine
in DNA and some of them have been exploited as drug tar-
gets in di¡erent pathologies. Deoxyuridine 5P-triphosphate nu-
cleotidohydrolase (dUTPase, EC 3.6.1.23) catalyzes the mag-
nesium-dependent hydrolysis of dUTP to dUMP and
pyrophosphate, providing the substrate for methylation of
uracil by thymidylate synthase and preventing accidental in-
corporation of uracil into DNA by DNA-polymerase [1].
The gene encoding dUTPase (dut) is present in most organ-
isms studied from viruses to higher eukaryotes. Deduced ami-
no acid sequences show a signi¢cant similarity de¢ned by 29^
36% identity and ¢ve amino acid consensus motifs [2]. Mono-
meric and trimeric dUTPases have been described [2^4], that
di¡er in the arrangement of these consensus motifs. For an
e⁄cient function, dUTPases have evolved to reach exquisite
substrate recognition, and therefore the uracil ring, the sugar
and even the triphosphate moieties are well distinguished. The
structure of four trimeric dUTPases has been solved [4^8].
They all show the same general architecture formed by a
L-barrel where the active sites are located in clefts between
two subunits and a £exible arm from the third subunit crosses
the molecule to act as a ‘lid’, which closes up when the sub-
strate is bound.
In the present report we describe the isolation of a gene
encoding a protein with dUTPase activity in Trypanosoma
cruzi, the etiologic agent of Chagas’ disease. The deduced
amino acid sequence is similar to that reported for Leishmania
major, di¡ering both from the de¢ned trimeric and mono-
meric family of dUTPases. Di¡erences found in trypanosoma-
tid dUTPases suggest that they belong to a di¡erent new
family of dUTP pyrophosphatases that di¡er in structure
and function to previously reported enzymes accomplishing
the same function.
2. Materials and methods
2.1. Cloning of the TCDUT gene
A T. cruzi Y strain cDNA expression library was made in V-ZAP
Express1 c-DNA Gigapack0 (Stratagene) and excision into the cor-
responding expression plasmids was performed assisted by helper V
phage.
Escherichia coli cells strain BW286 [v(xth-pncA), dut-1] were kindly
supplied from Bernard Weiss (Johns Hopkins University, Baltimore,
MD, USA) and transformed with the excised expression plasmids.
Replicated growing of transformed cells, at 28‡C and 37‡C, was
used. The colonies observed at 28‡C served as a test for the back-
ground e¡ect due to the frequent reversion in the phenotype of this
strain [9].
Automated sequencing and oligonucleotide biosynthesis was per-
formed at the Analytical Services of the Instituto de Parasitolog|¤a y
Biomedicina ‘Lo¤pez Neyra’. The sequence of the tcdut gene is avail-
able in GenBank with the accession number U93211.
2.2. T. cruzi dUTPase overexpression and puri¢cation
Recombinant T. cruzi dUTPase was produced using the pET 11
system. Pellets of dUTPase overexpressing cells were resuspended in
a solution consisting of bu¡er A (0.02 potassium phosphate, pH 6.5,
2 M dithiothreitol (DTT), 5 M MgCl2) plus protease inhibitors (1 mM
phenylmethylsulfonyl £uoride (PMSF), 1 Wg ml31 leupeptin, 1 mM
benzamidine). All reagents were from Sigma, except IPTG and leu-
peptin, which were from Boehringer. The soluble crude extract, ob-
tained by sonication, was directly loaded onto a hydroxyapatite chro-
matography column (Bio-Rad) at 1 ml min31. Elution was achieved
with a linear gradient of potassium phosphate (20^200 mM).
Active fractions from hydroxyapatite were pooled, diluted 1:2 with
bu¡er A and passed through a DEAE^cellulose chromatography col-
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umn (Whatman) pre-equilibrated with bu¡er A at 1 ml min31. Elution
from this column was performed with NaCl in a linear gradient from
0 to 200 mM.
2.3. Activity measurements
Continuous hydrolysis of dUTP was followed spectrophotometri-
cally taking advantage of the release of protons involved in the reac-
tion [10]. Cocktails of bu¡er/indicator used were MES/bromocresol
purple (375 WM/20 WM), pH 5.7^6.2, MOPS/bromothymol blue (625
WM/20 WM), pH 6.5^7.25, Bicine/cresol red (0.5^3 mM/25^50 WM),
pH 7.5^8.5, CHES/alizarine yellow (2 mM/50 WM), pH 9.0^10.0. Oth-
er additives in the reaction mixtures included 1 mg ml31 bovine serum
albumin and 5 mM MgCl2. pH indicators were all from Merck and
the remaining reagents were from Sigma. Concentration of high pure
nucleoside triphosphates (Pharmacia) or nucleoside diphosphates (Sig-
ma) was evaluated spectrophotometrically prior to dilution in reaction
bu¡er. Temperature for the measurements was set at 25‡C.
Initial absorbance values were recorded by starting the reactions
with a stopped-£ow accessory (Hi-Tech Scienti¢c) attached to a HP-
8453 UV-Visible spectrophotometer. Wavelengths of maximal absor-
bance for the basic species of the pH indicator were used for the time
course of the reaction. Data were collected and the resulting traces
were analyzed using the Michaelis^Menten integrated rate equation
with Microsoft Excel 97. For inhibition studies, Ki values were calcu-
lated as described [11]. 5P-O-(4-4P-dimethoxytrityl)-2P-deoxyuridine
(DMT-dU) and 2P-deoxyuridine 5P-(K,L-imido) diphosphate were
from Sigma and JenaBioScience respectively.
2.4. Crosslinking of dUTPase
The pure enzyme was incubated in 50 mM HEPES, pH 8.0, 0.1 mM
EDTA, 10 mM MgCl2, 0.5 mM DTT in the presence or absence of
100 WM disuccinimidyl suberate. The reaction was stopped at di¡erent
time intervals through precipitation with equal volumes of 50% tri-
chloroacetic acid and two consecutive washing steps with acetone.
Finally, the pellets were dissolved in SDS^PAGE sample bu¡er and
the sizes of the products generated in the reaction were analyzed in
12% polyacrylamide gels.
3. Results and discussion
3.1. Cloning of the TCDUT gene
In order to obtain the gene encoding dUTPase in T. cruzi, a
screening technique based on the de¢ciency in dUTPase ac-
tivity of the strain E. coli BW286 [9] was used. This approach
had been successfully used in the cloning of the human and
Leishmania dUTPase genes [12,13].
The analysis of the soluble crude extracts of positive clones
by SDS^PAGE showed the presence of a 32 kDa protein
overexpressed in two independent clones and a slightly higher
molecular mass protein in a third clone. The cDNA sequence
present in the ¢rst two clones was identical and corresponded
to complete mature mRNAs of T. cruzi. The characteristic
‘spliced leader’ sequence, present in all mRNAs from trypa-
nosomatids, was observed in the 5P-end [14] and the poly-A
tail was present in the 3P-end. The ¢rst initiation codon was
located 19 nucleotides downstream of the spliced leader and
an open reading frame of 849 encoded a protein sequence of
283 amino acids. The calculated molecular mass and isoelec-
tric point for the monomeric form were 32 065 Da and 5.16
respectively. The DNA sequence from the stop codon to the
poly-A tail was di¡erent in size from one clone to the other
(144 and 271 nucleotides respectively). The third clone con-
tained a 5P-truncated version of the gene TCDUT, starting at
the seventh coding triplet, and was expressed as a fusion pro-
tein together with the N-terminus of L-galatosidase. When the
cDNA sequence was analyzed, no signi¢cant similarity could
be established with the family of trimeric enzymes and, what
is more, the consensus motifs were absent. In contrast T. cruzi
dUTPase was highly similar to the reported sequence of the
trypanosomatid L. major [13] and the eubacteria Campylo-
bacter jejuni [15] (Fig. 1).
TCDUT also presents three motifs in common with an
enzyme related in function, the dCTPase^dUTPase from
phage T4 [13]. These motifs are conserved in the dCTPase^
dUTPase from T2 and in dUTPases from L. major and
C. jejuni (Fig. 1). The dCTPase has evolved to attain dUTPase
activity and interestingly this enzyme has capacity for the hy-
drolysis of the diphosphates derivatives dCDP and dUDP
[16]. In addition, an examination of the N-terminus reveals
the existence of basic amino acids in positions +3 and +9
characteristic of mitochondrial targeting sequences in the Try-
panosomatidae [17]. While distinct mitochondrial and nuclear
Fig. 1. Alignment of dUTPases from the trypanosomatids T. cruzi and L. major with the potential dUTPase gene from C. jejuni. Similarity
with T-even phages dCTPase^dUTPases is also shown. The alignment was made using the default parameters of the program PILE UP from
the GCG-package.
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isoforms have been described to exist in human cells in agree-
ment with the proposed role of dUTPase in DNA replication
[18] the exact subcellular localization of dimeric dUTPases
remains to be established. The availability of recombinant
enzyme will allow for antibody production and detailed intra-
cellular localization studies.
3.2. Native molecular mass
The molecular mass of the native protein was investigated
in pure recombinant protein by gel ¢ltration in Superdex 75
and was determined to be 62 445 Da in phosphate bu¡er both
in the presence and absence of 100 mM of magnesium, sug-
gesting that T. cruzi dUTPase is a stable dimer.
Subunit arrangement was also studied by using the cross-
linking agent DSS (suberic acid bis (N-hydroxy-succinimide
ester)). Analysis by SDS^PAGE showed the presence of a
64 kDa species which is absent in the lane corresponding to
untreated enzyme (Fig. 2) and again agrees with a dimeric
arrangement in the active protein unit. This result also agrees
with the fact that two molecules of protein per asymmetric
unit were described in crystals of this protein [19].
In the process of puri¢cation of recombinant T. cruzi dUT-
Pase the protein is cleaved into two peptides of similar size
when PMSF is omitted in the bu¡ers. The size of the peptides
generated, 15 and 17 kDa as estimated by SDS^PAGE, sug-
gests that T. cruzi dUTPase is speci¢cally recognized and
cleaved in the amino acid insertion not present in the sequence
of L. major (Fig. 1). The cleaved protein showed a dimeric
arrangement when analyzed by gel ¢ltration and was still
active (results not shown), suggesting that no dramatic
changes are originated in the overall structure after proteolytic
degradation.
3.3. Kinetic characterization and inhibition
Although the analysis of the progress curve obtained with
the Michaelis^Menten integrated rate enables calculation of
Km from a single curve, distinct values of Km were obtained
when the initial concentration of dUTP varied in the assay.
The apparent Km increased at higher concentrations of sub-
strate, suggesting a process of product inhibition similar to
what has been described for the Leishmania enzyme [20].
The integrated rate equation becomes more complex in this
case [21] and the estimation of Kms and inhibition constant of
the product (Kmp) is performed by replotting Km apparent
against initial dUTP concentrations. These calculations gave
a value for Km of 0.534 WM. On the other hand, Vmax re-
mained constant at di¡erent dUTP concentrations and per-
mitted an estimation of kcat of 2.8 s31, assuming two active
sites per dimer of dUTPase. The study of the kinetic behavior
of the enzyme demonstrated its equivalence in function pre-
viously reported [11,22]. While the low Km values described so
far (0.1^12 WM) would ensure very low dUTP concentrations
in the cell, the value of kcat, in the range of 1.5^25 s31, is
relatively low in comparison with other enzyme families (Ta-
ble 1). T. cruzi dUTPase was tested for capacity of hydrolysis
of the nucleosides triphosphate common in the cell (UTP,
dTTP, dCTP, dGTP and dATP). No appreciable hydrolysis
was observed in conditions where dUTP is fully hydrolyzed
and only in the case of dTTP a slow reaction appears to
occur. The determination of the kinetic constants for this
pseudo-substrate required much higher concentrations of
both enzyme and substrate, and the application of the inte-
grated rate equation was impracticable due to inability to
reach a situation of substrate saturation. Alternatively, a dif-
ferential method for analysis of the progress curve was applied
[23]. This method permitted an estimation of the kinetic pa-
rameters, showing a speci¢city constant Km/kcat 103-fold lower
than dUTP (Table 1).
A novel feature of trypanosomatid dUTPases is the obser-
vation that dUDP is an e⁄cient substrate. Most dUTPases
studied so far do not hydrolyze dUDP, which rather acts as a
competitive inhibitor [5,8,10]. The kinetic parameters of this
substrate were studied in detail. Again, an important product
inhibition was observed and the kinetic parameters were in-
vestigated by reacting enzyme with di¡erent initial concentra-
tions of substrate. The kcat and Km values obtained for dUDP
were three- and six-fold higher respectively, than for the tri-
phosphate derivative (Table 1).
Finally, the inhibition by DMT-dU, has been analyzed at
concentrations from 10 to 1500 WM. While this compound is
an e⁄cient inhibitor of E. coli dUTPase, the Ki value obtained
for the T. cruzi enzyme was greater than 2500 WM indicating
again, as for the Leishmania enzyme [11], possible structural
di¡erences and the possibility of a speci¢c inhibition of dimer-
ic enzymes. On the other hand, K-L-imido-dUDP proved to
be an e¡ective inhibitor of the enzyme with a Ki value of
Fig. 2. Crosslinking of T. cruzi dUTPase. Lane 1: recombinant pro-
tein in the absence of DSS incubated 120 min at 37‡C. Lanes 2^6:
dUTPase incubated with 100 WM DSS during 5, 10, 30, 60 and 120
min respectively.
Table 1
Michaelis^Menten, speci¢city and inhibition constants of viral, bacterial and trypanosomatid dUTPases towards di¡erent nucleotides
Nucleotide T. cruzi L. major E. coli EIAV HSV-1 MMTV
dUTP:Km (kcat/Km) 0.5 (5.2U106) 2.1 (2.3U107) 0.2 (4U107) 1.1 (2U107) 0.3 (2U107) 0.8 (2U106)
dTTP:Km (kcat/Km) s 800 (2.5U103) 1514 (5.5U103) s 20000 (34) 260 (6 2000) 400 (1000) nd (2000)
dCTP:Km (kcat/Km) nd s 2500 (5.0U103) 4000 (6 100) 3000 (1000) 1000 (2000) nd
UTP:Km (kcat/Km) nd s 2500 (2.0U103) 2500 (6 100) nd 1000 (200) nd
dUDP:Km (kcat/Km) 6.2 (1.7106) 62.7 (1U106) Ki = 15 Ki = 3.6 Ki = 17 nd
dUMP:Kip 18.4 13.1 1500 130 170 nd
Units for Km and Ki are WM and for kcat/Km M31 s31. nd, not determined.
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0.24 WM, in agreement with the observation that the enzyme
binds e¡ectively nucleoside diphosphates.
In summary, no sequence similarity with other dUTPases,
dimeric conformation of the active protein and e⁄cient hy-
drolysis of dUDP are all features common to trypanosomatid
dUTPases which appear to form a new family of dUTPases
with distinct structural and functional characteristics. Crystals
of T. cruzi dUTPase have been obtained [19]. The determina-
tion of the three dimensional structure of this protein will help
to de¢ne speci¢c di¡erences that may be exploitable in the
design of inhibitors useful in the development of new drugs
for Chagas’ disease therapy.
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